Fredun Pharmaceuticals

FREDUN

SectorHealthcare

Insights Financials Evidence

‌
‌
‌
‌
‌
‌
‌
‌

‌

‌
‌

‌
‌
‌

‌
‌

‌

‌
‌
‌
‌
‌
‌
‌

‌
‌
‌
‌
‌
‌

Fredun Pharmaceuticals Stock Price - ₹1,477.70 | Healthcare | askfuzz

Fredun Pharmaceuticals

FREDUN

SectorHealthcare

Insights Financials Evidence

‌
‌
‌
‌
‌
‌
‌
‌

Announcements

Exchange filings, newest first

8 Oct
22 Sept
8 Sept

Documents by quarter

Results, presentation and transcript tracked for every quarter

Transcript Q1 FY2026-27

13 pages

Quarterly Result Q1 FY2026-27

3 pages

Annual Reports

Management Discussion, Balance Sheet and more

Annual Reports 2025-26

26 pages

Annual Reports 2024-25

239 pages

Annual Reports 2023-24

207 pages

Other Filings

KMP changes, governance and LODR disclosures

DateFilingCategory

8 Oct 2026Fredun Pharmaceuticals Ltd press release on strategic pet-care deals, wellness launches, capacity expansion, and bonus issue plansRestructuring

3 Oct 2026Fredun Pharmaceuticals Ltd board allots 1,82,400 equity shares to non-promoters upon conversion of warrants on 03 Oct 2026Capital Raise

22 Sept 2026Fredun Pharmaceuticals Ltd allotment of 3,61,599 equity shares upon conversion of warrants on 16 Sep 2026Capital Raise

22 Sept 2026Fredun Pharmaceuticals Ltd acquires 26% stake in Goodman Vetcare Pvt. Ltd. for strategic expansion in pet-care marketRestructuring

16 Sept 2026Fredun Pharmaceuticals Ltd allotment of 2,71,200 equity shares upon conversion of warrants on 16 Sep 2026Capital Raise

10 Jul 2026Fredun Pharmaceuticals Ltd record date for bonus issue (2:1) on 16 Jul 2026Record Date

29 May 2026Fredun Pharmaceuticals Limited Annual Secretarial Compliance Report for FY26 under Regulation 24A filed on 29 May, 2026Audit Reports